148 related articles for article (PubMed ID: 6462108)
1. Lack of in vitro activity of cefoxitin, cefamandole, cefuroxime, and piperacillin against Chlamydia trachomatis.
Bowie WR
Antimicrob Agents Chemother; 1982 Feb; 21(2):339-40. PubMed ID: 6462108
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
George WL; Lewis RP; Meyer RD
Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
Sutter VL; Kirby B; Finegold SM
Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
[TBL] [Abstract][Full Text] [Related]
4. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
Thabaut A; Durosoir JL; Saliou P
Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
[TBL] [Abstract][Full Text] [Related]
5. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
Barry AL; Jones RN; Thornsberry C
Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
[TBL] [Abstract][Full Text] [Related]
8. [In vitro studies with piperacillin. Effectiveness against enterobacteriaceae and pseudomonas aeruginosa compared to other antibiotics (author's transl)].
Baier R; Puppel H
Med Klin; 1979 Dec; 74(50):1923-7. PubMed ID: 120489
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity and synergism of cefuroxime on anaerobic bacteria.
Thadepalli H; White DW; Bach VT
Chemotherapy; 1981; 27(4):252-8. PubMed ID: 7249787
[TBL] [Abstract][Full Text] [Related]
10. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
Harper PB
Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
[TBL] [Abstract][Full Text] [Related]
11. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
Mirimanoff RO; Héraïef E
Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
[No Abstract] [Full Text] [Related]
12. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
Brorson JE; Norrby R
Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
[No Abstract] [Full Text] [Related]
13. Relationship between cefamandole and cefuroxime activity against oxacillin-resistant Staphylococcus epidermidis and oxacillin resistance phenotype.
Woods GL; Knapp CC; Washington JA
Antimicrob Agents Chemother; 1987 Sep; 31(9):1332-7. PubMed ID: 3674845
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of cefmenoxime, cefotaxime, cefuroxime, cefoxitin, and penicillin against Neisseria gonorrhoeae.
Khan MY; Siddiqui Y; Simpson ML; Gruninger RP
Antimicrob Agents Chemother; 1981 Nov; 20(5):681-2. PubMed ID: 6275781
[TBL] [Abstract][Full Text] [Related]
15. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.
Knothe H; Shah P; Krcmery V; Antal M; Mitsuhashi S
Infection; 1983; 11(6):315-7. PubMed ID: 6321357
[TBL] [Abstract][Full Text] [Related]
16. Effect of cefamandole, cefuroxime and cefoxitin on yeast fecal flora of surgical patients.
Thomakos N; Maraki S; Liakakos T; Macheras A; Kanavaki S; Marinis E; Sehas M; Margioris AN; Samonis G
Chemotherapy; 1998; 44(5):324-7. PubMed ID: 9732147
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Thabaut A; Durosoir JL; Saliou P
Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis.
Martin DH; Pastorek JG; Faro S
Sex Transm Dis; 1986; 13(2):81-7. PubMed ID: 3520886
[TBL] [Abstract][Full Text] [Related]
19. Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime.
Rylander M; Brorson JE; Johnsson J; Norrby R
Antimicrob Agents Chemother; 1979 Apr; 15(4):572-9. PubMed ID: 464588
[TBL] [Abstract][Full Text] [Related]
20. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
Tartaglione TA; Polk RE
Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
